Skip to content
TrialScanner

NCT04412057

Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury

Phase 2CompletedAVTXLead

Registry record

Lead sponsor
Aevi Genomic Medicine, LLC, a Cerecor company
Conditions
COVID-19 Pneumonia; Acute Lung Injury; ARDS
Primary completion
Dec 14, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04412057 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04412057: Clinical Trial to Evaluate... | TrialScanner